|
CST3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33226762955019E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.34720001820909E-09 |
| Normal-vs-Stage2 |
6.627000E-04 |
| Normal-vs-Stage3 |
1.5384999940693E-09 |
| Normal-vs-Stage4 |
2.49333886870318E-12 |
| Stage1-vs-Stage2 |
8.732000E-01 |
| Stage1-vs-Stage3 |
3.024300E-02 |
| Stage1-vs-Stage4 |
2.538200E-03 |
| Stage2-vs-Stage3 |
1.842230E-01 |
| Stage2-vs-Stage4 |
4.444100E-02 |
| Stage3-vs-Stage4 |
5.767600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6698864513387E-12 |
| Normal-vs-AfricanAmerican |
5.55209999975048E-07 |
| Normal-vs-Asian |
5.102000E-03 |
| Caucasian-vs-AfricanAmerican |
4.378200E-02 |
| Caucasian-vs-Asian |
9.038400E-01 |
| AfricanAmerican-vs-Asian |
3.844800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.93350000010639E-07 |
| Male-vs-Female |
2.106300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.202500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.13686837721616E-13 |
| Normal-vs-Age(61-80Yrs) |
2.8475000135586E-10 |
| Normal-vs-Age(81-100Yrs) |
3.702900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.795800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.422350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.067000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.220200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.099600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.797200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.568800E-01 |
| Normal-vs-Grade 2 |
1.15229999986255E-07 |
| Normal-vs-Grade 3 |
1.69642078162724E-13 |
| Normal-vs-Grade 4 |
1.05593311872099E-12 |
| Grade 1-vs-Grade 2 |
1.786220E-01 |
| Grade 1-vs-Grade 3 |
2.738200E-03 |
| Grade 1-vs-Grade 4 |
3.97230000004356E-06 |
| Grade 2-vs-Grade 3 |
6.801200E-03 |
| Grade 2-vs-Grade 4 |
1.50030000001244E-06 |
| Grade 3-vs-Grade 4 |
8.167300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.056100E-02 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.63236091310637E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56009649643352E-11 |
| Normal-vs-N1 |
3.655100E-03 |
| N0-vs-N1 |
5.273500E-02 |
|
|
